Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China · Delayed Price · Currency is CNY 32.16
+0.34 (1.07%)
Feb 3, 2026, 3:04 PM CST
SHE:002940 Revenue
Zhejiang AngLiKang Pharmaceutical CO.,LTD. had revenue of 330.81M CNY in the quarter ending September 30, 2025, with 20.67% growth. This brings the company's revenue in the last twelve months to 1.45B, down -6.97% year-over-year. In the year 2024, Zhejiang AngLiKang Pharmaceutical CO.,LTD. had annual revenue of 1.51B, down -6.63%.
Revenue (ttm)
1.45B
Revenue Growth
-6.97%
P/S Ratio
4.36
Revenue / Employee
1.13M
Employees
1,275
Market Cap
6.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.51B | -107.47M | -6.63% |
| Dec 31, 2023 | 1.62B | 52.13M | 3.32% |
| Jan 1, 2023 | 1.57B | 188.06M | 13.62% |
| Jan 1, 2022 | 1.38B | 90.73M | 7.04% |
| Dec 31, 2020 | 1.29B | -106.55M | -7.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.22B |
| Guizhou Xinbang Pharmaceutical | 5.73B |
| Jinghua Pharmaceutical Group | 1.45B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.43B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.17B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.04M |
| Chongqing Pharscin Pharmaceutical | 786.51M |
| ChengDu ShengNuo Biotec | 638.35M |